Infectious Disease and Respiratory Virus Research
Research activity is centred on influenza virus, with interest in prevention and clinical management of seasonal viral infection.
- Influenza prevention
- Viral respiratory infection
- Healthy adult participants
The sponsor’s current clinical focus is directed toward reducing influenza-related illness and assessing safety and tolerability in adults.
Antiviral Therapeutic Development
The funded research includes evaluation of an antiviral approach intended to limit clinically meaningful outcomes associated with influenza infection.
- Clinical influenza outcomes
- Symptom burden reduction
- Protective immune targeting
Its therapeutic interest lies in interventions designed for direct use against circulating respiratory viruses.
Immunology and Neutralising Antibody Research
The sponsor’s research landscape includes antibody-based strategies aimed at interfering with influenza virus activity through immune-mediated mechanisms.
- Neutralising antibodies
- Immune-mediated viral control
- Host-pathogen interaction
This area reflects a therapeutic interest in biologic approaches for viral disease control.
